# Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)

> **NCT03779490** · — · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 150 (estimated)

## Conditions studied

- Tricuspid Regurgitation
- Tricuspid Insufficiency

## Interventions

- **DEVICE:** Transcatheter Tricuspid Valve Repair

## Key facts

- **NCT ID:** NCT03779490
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-24
- **Primary completion:** 2022-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779490, "Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03779490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*